This activity is relatively rare among PI3K/mTOR dual inhibitors, although various anticancer agents, such as curcumin and cisplatin, can trigger the nonapoptotic death of cancer cells (Chen et al., 2013; Qiu et al., 2014; Xie et al., 2017). Here, PIK3CA is linked to cancer.